Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1996 1
2002 1
2008 1
2011 2
2012 2
2013 2
2015 2
2016 2
2017 5
2018 6
2019 3
2020 2
2021 2
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

28 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Potential Therapeutic Effects of Psilocybin.
Johnson MW, Griffiths RR. Johnson MW, et al. Neurotherapeutics. 2017 Jul;14(3):734-740. doi: 10.1007/s13311-017-0542-y. Neurotherapeutics. 2017. PMID: 28585222 Free PMC article. Review.
However, in the twenty-first century, scientific interest in classic psychedelics has returned and grown as a result of several promising studies, validating earlier research. ...For addiction, small, open-label pilot studies have shown promising success rate …
However, in the twenty-first century, scientific interest in classic psychedelics has returned and grown as a result of several promi …
Psychedelic drugs-a new era in
psychiatry?
.
Nutt D. Nutt D. Dialogues Clin Neurosci. 2019;21(2):139-147. doi: 10.31887/DCNS.2019.21.2/dnutt. Dialogues Clin Neurosci. 2019. PMID: 31636488 Free PMC article. Review.
These drugs were used quite extensively before they became prohibited. This ban had little impact on recreational use, but effectively stopped research and clinical treatments, which up to that point had looked very promising in several areas of psychiatry. ...These …
These drugs were used quite extensively before they became prohibited. This ban had little impact on recreational use, but effectively
Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern-era clinical studies.
Andersen KAA, Carhart-Harris R, Nutt DJ, Erritzoe D. Andersen KAA, et al. Acta Psychiatr Scand. 2021 Feb;143(2):101-118. doi: 10.1111/acps.13249. Epub 2020 Dec 1. Acta Psychiatr Scand. 2021. PMID: 33125716 Review.
The reviewed studies established feasibility and evidence of safety, alongside promising early data of efficacy in the treatment of depression, anxiety, OCD, and tobacco and alcohol use disorders. For a majority of patients, the therapeutic effects app …
The reviewed studies established feasibility and evidence of safety, alongside promising early data of efficacy in the treatment
Studying the effects of classic hallucinogens in the treatment of alcoholism: rationale, methodology, and current research with psilocybin.
Bogenschutz MP. Bogenschutz MP. Curr Drug Abuse Rev. 2013 Mar;6(1):17-29. doi: 10.2174/15733998113099990002. Curr Drug Abuse Rev. 2013. PMID: 23627783 Review.
Recent developments in the study of classic hallucinogens, combined with a re-appraisal of the older literature, have led to a renewal of interest in possible therapeutic applications for these drugs, notably their application in the treatment of addic …
Recent developments in the study of classic hallucinogens, combined with a re-appraisal of the older literature, have l …
Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study.
Bogenschutz MP, Forcehimes AA, Pommy JA, Wilcox CE, Barbosa PC, Strassman RJ. Bogenschutz MP, et al. J Psychopharmacol. 2015 Mar;29(3):289-99. doi: 10.1177/0269881114565144. Epub 2015 Jan 13. J Psychopharmacol. 2015. PMID: 25586396 Clinical Trial.
Several lines of evidence suggest that classic (5HT2A agonist) hallucinogens have clinically relevant effects in alcohol and drug addiction. Although recent studies have investigated the effects of psilocybin in various populations, there …
Several lines of evidence suggest that classic (5HT2A agonist) hallucinogens have clinically relevant effects in alc
Classic hallucinogens in the treatment of addictions.
Bogenschutz MP, Johnson MW. Bogenschutz MP, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2016 Jan 4;64:250-8. doi: 10.1016/j.pnpbp.2015.03.002. Epub 2015 Mar 14. Prog Neuropsychopharmacol Biol Psychiatry. 2016. PMID: 25784600 Review.
Addictive disorders are very common and have devastating individual and social consequences. Currently available treatment is moderately effective at best. After many years of neglect, there is renewed interest in potential clinical uses for classic halluc
Addictive disorders are very common and have devastating individual and social consequences. Currently available treatment is moderat …
Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function.
Johnson MW, Hendricks PS, Barrett FS, Griffiths RR. Johnson MW, et al. Pharmacol Ther. 2019 May;197:83-102. doi: 10.1016/j.pharmthera.2018.11.010. Epub 2018 Dec 4. Pharmacol Ther. 2019. PMID: 30521880 Review.
These studies have shown classic psychedelics to fairly reliably occasion mystical experiences. ...Finally, we review neuroimaging studies that suggest neurobiological mechanisms of classic psychedelics. ...
These studies have shown classic psychedelics to fairly reliably occasion mystical experiences. ...Finally, we review neuroima …
Long-term follow-up of psilocybin-facilitated smoking cessation.
Johnson MW, Garcia-Romeu A, Griffiths RR. Johnson MW, et al. Am J Drug Alcohol Abuse. 2017 Jan;43(1):55-60. doi: 10.3109/00952990.2016.1170135. Epub 2016 Jul 21. Am J Drug Alcohol Abuse. 2017. PMID: 27441452 Free PMC article. Clinical Trial.
METHODS: The present report describes biologically verified smoking abstinence outcomes of the previous pilot study at 12 months, and related data on subjective effects of psilocybin. ...The present study adds to recent and historical evidence suggesting high …
METHODS: The present report describes biologically verified smoking abstinence outcomes of the previous pilot study at 12 months, and …
Therapeutic Applications of Classic Hallucinogens.
Bogenschutz MP, Ross S. Bogenschutz MP, et al. Curr Top Behav Neurosci. 2018;36:361-391. doi: 10.1007/7854_2016_464. Curr Top Behav Neurosci. 2018. PMID: 28512684 Review.
Following a review of the history of human use and scientific study of these drugs, the data from clinical research are summarized, including extensive work on the use of classic hallucinogens in the treatment of alcoholism and other addictions, …
Following a review of the history of human use and scientific study of these drugs, the data from clinical research are summarized, i …
Why MDMA therapy for alcohol use disorder? And why now?
Sessa B. Sessa B. Neuropharmacology. 2018 Nov;142:83-88. doi: 10.1016/j.neuropharm.2017.11.004. Epub 2017 Nov 7. Neuropharmacology. 2018. PMID: 29126911 Review.
Current treatments, both psychological and pharmacological are poor, with high rates of relapse after medical detoxification and dedicated treatment programs. ...Given that alcohol use disorder is so often associated with early traumatic experiences, the auth …
Current treatments, both psychological and pharmacological are poor, with high rates of relapse after medical detoxification and dedi …
28 results